Pathstone Family Office’s Neurogene NGNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-100
Closed -$28K 1086
2020
Q4
$28K Buy
+100
New +$28K ﹤0.01% 617